Cisplatin in breast cancer.

por Willemse, P., Sleijfer, D. T., Mulder, N. H., de Vries, E. G.
Publicado 1993

Acute and cumulative effects of carboplatin on renal function.

por Sleijfer, D. T., Smit, E. F., Meijer, S., Mulder, N. H., Postmus, P. E.
Publicado 1989

A phase II study of oral etoposide in elderly patients with small cell lung cancer.

por Smit, E F, Carney, D N, Harford, P, Sleijfer, D T, Postmus, P E
Publicado 1989

The tumor microenvironment: possible role of integrins and the extracellular matrix in tumor biological behavior of intratubular germ cell neoplasia and testicular seminomas.

por Timmer, A., Oosterhuis, J. W., Schraffordt Koops, H., Sleijfer, D. T., Szabo, B. G., Timens, W.
Publicado 1994

Dacarbazine (DTIC) and human recombinant interferon alpha 2a (Roferon) in the treatment of disseminated malignant melanoma.

por Mulder, N. H., Willemse, P. H., Schraffordt Koops, H., de Vries, E. G., Sleijfer, D. T.
Publicado 1990

Dacarbazine (DTIC), human recombinant interferon alpha 2a (Roferon) and 5-fluorouracil for disseminated malignant melanoma.

por Mulder, N. H., de Vries, E. G., Sleijfer, D. T., Schraffordt Koops, H., Willemse, P. H.
Publicado 1992

Peripheral blood lymphocyte number and phenotype prior to therapy correlate with response in subcutaneously applied rIL-2 therapy of renal cell carcinoma.

por Janssen, R. A., Sleijfer, D. T., Heijn, A. A., Mulder, N. H., The, T. H., de Leij, L.
Publicado 1992

Palmar fasciitis and arthritis in a patient with an extraovarian adenocarcinoma of the coelomic epithelium.

por Willemse, P H, Mulder, N H, van de Tempel, H J, Aalders, J G, Sleijfer, D T
Publicado 1991

Early sCD8 plasma levels during subcutaneous rIl-2 therapy in patients with renal cell carcinoma correlate with response.

por Martens, A., Janssen, R. A., Sleijfer, D. T., Heijn, A. A., Mulder, N. H., The, T. H., de Leij, L.
Publicado 1993

High dose etoposide for brain metastases of small cell lung cancer. A phase II study. The EORTC Lung Cancer Cooperative Group.

por Postmus, P. E., Haaxma-Reiche, H., Sleijfer, D. T., Kirkpatrick, A., McVie, J. G., Kleisbauer, J. P.
Publicado 1989

Pharmacokinetics of carboplatin at a dose of 750 mg m-2 divided over three consecutive days.

por Mulder, P. O., de Vries, E. G., Uges, D. R., Scaf, A. H., Sleijfer, D. T., Mulder, N. H.
Publicado 1990

Dacarbazine (DTIC)-based chemotherapy or chemoimmunotherapy of patients with disseminated malignant melanoma.

por Mulder, N. H., van der Graaf, W. T., Willemse, P. H., Koops, H. S., de Vries, E. G., Sleijfer, D. T.
Publicado 1994

Immunomodulatory effects of intravenous BIS-1 F(ab')2 administration in renal cell cancer patients.

por Janssen, R. A., Kroesen, B. J., Buter, J., Mesander, G., Sleijfer, D. T., The, T. H., Mulder, N. H., de Leij, L.
Publicado 1995

Resection of residual retroperitoneal masses in testicular cancer: evaluation and improvement of selection criteria. The ReHiT study group. Re-analysis of histology in testicular c...

por Steyerberg, E. W., Keizer, H. J., Fosså, S. D., Sleijfer, D. T., Bajorin, D. F., Donohue, J. P., Habbema, J. D.
Publicado 1996

Bacteriological aspects of selective decontamination of the digestive tract as a method of infection prevention in granulocytopenic patients.

por de Vries-Hospers, H G, Sleijfer, D T, Mulder, N H, van der Waaij, D, Neiweg, H O, van Saene, H K
Publicado 1981

Phase I study of intravenously applied bispecific antibody in renal cell cancer patients receiving subcutaneous interleukin 2.

por Kroesen, B. J., Buter, J., Sleijfer, D. T., Janssen, R. A., van der Graaf, W. T., The, T. H., de Leij, L., Mulder, N. H.
Publicado 1994

Four cycles of BEP vs four cycles of VIP in patients with intermediate-prognosis metastatic testicular non-seminoma: a randomized study of the EORTC Genitourinary Tract Cancer Coop...

por de Wit, R., Stoter, G., Sleijfer, D. T., Neijt, J. P., ten Bokkel Huinink, W. W., de Prijck, L., Collette, L., Sylvester, R.
Publicado 1998

Cardiotoxicity from intensive chemotherapy combined with radiotherapy in breast cancer.

por de Graaf, H., Dolsma, W. V., Willemse, P. H., van der Graaf, W. T., Sleijfer, D. T., de Vries, E. G., Mulder, N. H.
Publicado 1997

A phase I study of 1,2-diamminomethyl-cyclobutane-platinum (II)-lactate (D-19466; lobaplatin) administered daily for 5 days.

por Gietema, J. A., de Vries, E. G., Sleijfer, D. T., Willemse, P. H., Guchelaar, H. J., Uges, D. R., Aulenbacher, P., Voegeli, R., Mulder, N. H.
Publicado 1993

Activity of high-dose epirubicin combined with gemcitabine in advanced non-small-cell lung cancer: a multicenter phase I and II study

por van Putten, J W G, Eppinga, P, Erjavec, Z, de Leede, G, Nabers, J, Smeets, J B E, Sleijfer, D Th, Groen, H J M
Publicado 2000